Vol. 4 No. 1 (2025): Vol 4 Issue 1 2025

Articles

• Translational Failure in Neurodegeneration: What Two Decades of Negative Trials Should Change About Target Selection

  Neza Zupanic, Alexandra Chirica, Guro Haugsdal (Author)

  1-9

  • pdf

• GLP-1 Receptor Agonist Repurposing Across Indications: Mechanism, Evidence and Trial Sequencing

  Kristaps Rudzitis, Ari Gudlaugsson, Anja Cvetkovski (Author)

  10-18

  • pdf

• Organ-on-Chip Models in Regulatory Submissions: A Perspective on Evidentiary Weight

  Fien Wauters, Hendrik Hasselwander, Vuk Zdravkovic (Author)

  19-27

  • pdf

• Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal

  Sander Poldsepp, Yannick Cavegn, Emilija Sabaliauskiene (Author)

  28-36

  • pdf

• Early Phase Trial Participation Among Under-Served Groups: Barriers Measured at Screening

  Razvan Preda-Muresan, Nemanja Nedeljkovic, Danica Azzopardi (Author)

  37-45

  • pdf

• Drug-Induced Liver Injury From a Herbal Adjunct During an Oncology Trial: A Case Report

  Marloes Vreeswijk, Sergio Marimon, Corrado Tagliaferro (Author)

  46-54

  • pdf